MEDNAX, Inc. (MD) Tops Q2 EPS by 1c; Approves Buyback Plan
Tweet Send to a Friend
MEDNAX, Inc. (NYSE: MD) reported Q2 EPS of $1.37, $0.01 better than the analyst estimate of $1.36. Revenue for the ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
